To evaluate the efficacy and safety of LAS 34273 compared to placebo in patients with moderate to severe COPD during one year of treatment.
Official Title
Conditions
- Chronic Obstructive Pulmonary Disease
Study Type
Interventional
Study Design
Randomized, Double-Blind, Placebo Control, Parallel Assignment
Further Details
- Primary Outcomes: Lung function
- Secondary Outcomes: Exacerbations and Quality of Life
Study Start
July 2006
Eligibility & Criteria
- Ages Eligible for Study: 40 Years and above
- Genders Eligible for Study: Both
Inclusion Criteria:
- Males and females aged > 40 years with a clinical diagnosis of moderate to severe stable COPD
Exclusion Criteria:
- History or current diagnosis of asthma, recent respiratory tract infection or acute COPD exacerbation, life expectancy of less than 1 year, known symptomatic prostatic hypertrophy, bladder neck obstruction or narrow-angle glaucoma
Total Enrolment
Contact Details
Brisbane South Clinical Research Centre, Brisbane, Queensland, 4152, Australia; Recruiting
All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.
Related Articles
Need a health appointment?
Find and book a doctor, dentist, physio and more on Healthengine
Find a practitioner
